Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Advances in Musculoskeletal Disease is Scopus-indexed (Q1, CiteScore 7.8), WoS SCIE, DOAJ. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 1759-720XVerify ISSN ↗1759-7218Verify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Orthopedics and Sports Medicine | 20 / 340 | 94th | Q1 |
| Rheumatology | 13 / 77 | 83rd | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q1, CiteScore 7.8.
Therapeutic Advances in Musculoskeletal Disease is Q1 in Orthopedics and Sports Medicine (rank 20 of 340) and Q1 in Rheumatology (rank 13 of 77), by CiteScore 2025.
Therapeutic Advances in Musculoskeletal Disease is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.8, which places it in quartile Q1 at the 94th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.190, quartile Q1, with an H-index of 59.
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Therapeutic Advances in Musculoskeletal Disease is published by SAGE Publications Inc. Its print ISSN is 1759-720X and its online ISSN is 1759-7218.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Therapeutic Advances in Musculoskeletal Disease has an h-index of 70 and a 2-year mean of 3.54 citations per paper (OpenAlex). Its Scopus CiteScore is 7.8, quartile Q1. On 2-year citations it ranks #32 of 331 Scopus journals in Orthopedics and Sports Medicine.
Therapeutic Advances in Musculoskeletal Disease published 49 papers in 2025; its busiest recent year was 2021 with 111. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (16.5%), Italy (12.7%) and Spain (7.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.